Medical Advisory Council | ThyCa: Thyroid Cancer Survivors' Association, Inc.

ThyCa is committed to providing the most accurate and up-to-date thyroid cancer information. Our volunteer Medical Advisory Council (MAC) is composed of distinguished leading multi-disciplinary medical professionals working within the thyroid cancer field, representing many of the major cancer centers. All have made outstanding contributions in their own fields and review the information we provide. We are honored to have their involvement on our behalf.

All MAC members contribute their expertise to ThyCa on a pro bono basis with no conflict of interest between their professional work and their volunteer work. We are honored to have their involvement on our behalf.

Erik K. Alexander, M.D.

Endocrinologist

Brigham and Women's Hospital, Harvard Medical School Boston, MA

Erik K. Alexander, M.D. is Chief of the Thyroid Section, Brigham and Women’s Hospital, and Professor of Medicine at Harvard Medical School. Dr. Alexander has published over 150 peer-reviewed articles, mostly focused on the optimal evaluation of thyroid nodules and prevention of unnecessary thyroid surgery. Seminal articles have published in the New England Journal of Medicine, and the Annals of Internal Medicine. Dr. Alexander is a member of the 2016 American Thyroid Association Guideline Committee on the Care of Patients with Thyroid Nodules and Thyroid Cancer, and recently was co-chairman of a separate 2017 ATA Guideline on the Care of Patients with Thyroid Disease During Pregnancy. Dr. Alexander is a past member of the ATA Board of Directors, and frequently speaks at National and International conferences on thyroid disease. He is an active clinician, caring for over 40 patients each week.

Peter Angelos, M.D., Ph.D.

Endocrine Surgeon

University of Chicago Chicago, IL

Peter Angelos, M.D., Ph.D., FACS, is the Linda Kohler Anderson Professor of Surgery and Surgical Ethics, Chief of Endocrine Surgery, and Associate Director of the MacLean Center for Clinical Medical Ethics at the University of Chicago. He completed his undergraduate degree, medical school, and a Ph.D. in Philosophy at Boston University. He completed his residency in General Surgery at Northwestern University and went on to complete fellowships in Clinical Ethics at the University of Chicago and in Endocrine Surgery at the University of Michigan. Dr. Angelos is a busy endocrine surgeon who has written widely on improving outcomes of thyroid and parathyroid surgery, minimally invasive endocrine surgery, and ethical aspects in the care of surgical patients. He will serve as President of the American Association of Endocrine Surgeons 2016-2017.

Douglas W. Ball, M.D.

Endocrinologist

Johns Hopkins Medical Institutions Baltimore, MD

Douglas W. Ball, M.D., Endocrinologist, Johns Hopkins Medical Institutions, Baltimore, Maryland, is a clinician and researcher specializing in Thyroid Cancer, Medullary Thyroid Cancer, and Multiple Endocrine Neoplasia. His laboratory studies mechanisms underlying the neuroendocrine phenotype seen in some human cancers. Dr. Ball is active in developing new therapies for medullary thyroid cancer, and works in this translational research program in collaboration with other researchers and clinicians. Dr. Ball graduated from George Washington University Medical School and completed further training in Internal Medicine and in Endocrinology and Metabolism at the University of Pittsburgh and Johns Hopkins University. He is the author of numerous peer-reviewed medical journal articles and has been a speaker at previous ThyCa educational events.

Andrew J. Bauer, M.D., F.A.A.P.

Endocrinologist

The Children's Hospital of Philadelphia Philadelphia, PA

Andrew J Bauer, M.D. is Associate Professor of Pediatrics at the Perelman School of Medicine, University of Pennsylvania, and serves as the director of Children's Hospital of Philadelphia's Thyroid Center. Dr. Bauer retired from the United States Army after 29 years of service, to include two combat tours in Iraq. Dr. Bauer’s clinical and research interests are focused on the study of pediatric thyroid disorders, including hyperthyroidism, hypothyroidism, thyroid nodular disease, thyroid cancer, and familial thyroid tumor syndromes. Dr. Bauer serves as chair of the American Thyroid Association’s (ATA) pediatric thyroid cancer guidelines and as a member of the ATA’s Board of Directors. In 2018, Dr. Bauer served on the World Health Organization, International Agency for Research on Cancer expert group that published guidelines on thyroid screening after nuclear disasters. He has spoken at many ThyCa events.

Keith C. Bible, M.D., Ph.D.

Medical Oncologist

Mayo Clinic Rochester, MN

Keith C. Bible, M.D., Ph.D., is Chair of the Endocrine Malignancies Disease-Oriented Group at the Mayo Clinic Cancer Center in Rochester, Minnesota. He combines clinical practice as a medical oncologist with basic, translational, and clinical research initiatives directed toward the ultimate goal of improving therapies for patients with cancer. He is a member of the Differentiated Thyroid Carcinoma Management Guidelines Task Force and Anaplastic Thyroid Carcinoma Management Guidelines Task Forces of the American Thyroid Association. He received his M.D. degree at the University of Illinois College of Medicine, and his Ph.D. in Organic Chemistry at the University of Illinois at Urbana-Champaign, followed by residency and clinical and research fellowships at the Mayo Clinic.

Marcia S. Brose, M.D., Ph.D.

Medical Oncologist

Thomas Jefferson University Philadelphia, PA

Marcia S. Brose, M.D., Ph.D., is a Medical Oncologist and Assistant Professor at Thomas Jefferson University in Philadelphia, Pennsylvania, where she is involved in clinical trials of new treatments for patients with advanced thyroid cancer. Her clinical focus is familial cancer syndromes and cancer risk evaluation, Phase I/II clinical trials, and novel drug target discovery. Her research focuses on genomic characterization of cancers of the head and neck, thyroid, and lung; novel drug target discovery; and the use of genetic testing in the diagnosis, prognostication, and treatment of cancer. Dr. Brose received her bachelor's degree from Amherst College, her medical degree from Cornell University Medical College, and her Ph.D. from The Rockefeller University.

Kenneth D. Burman, M.D.

Endocrinologist

Washington Hospital Center Washington, DC

Kenneth D. Burman, M.D., is Director of the Section of Endocrinology at the Washington Hospital Center in Washington, D.C.. His appointments also include Professor of Medicine at the Uniformed Services University of the Health and Sciences, Georgetown University of Medicine, and George Washington University School of Medicine. After graduating from the University of Missouri Medical School, he completed his internship and residency at Barnes Hospital and a fellowship in endocrinology at Walter Reed Army Medical Center. Dr. Burman is board certified in internal medicine as well as endocrinology and metabolism, and is also certified as a specialist in clinical nutrition by the American Board of Nutrition. He currently serves on several committees for the American Thyroid association Council; is a member of the editorial board of Thyroid; is a frequent invited lecturer; and has received awards for patient care, research and teaching.

Naifa L. Busaidy, M.D.

Endocrinologist

University of Texas MD Anderson Cancer Center Houston, TX

Naifa L. Busaidy, M.D., is an Endocrinologist and Assistant Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston, Texas. She is a graduate of Baylor College of Medicine in Houston. She completed postgraduate training at The Royal Hospital and the Sultan Qaboos University Hospital, Oman; Baylor College of Medicine, Houston, Texas; and University of Texas MD Anderson Cancer Center, Houston, Texas. She is the author of numerous research articles and book chapters. Dr. Busaidy is also the recipient of a ThyCa thyroid cancer research grant.

Maria E. Cabanillas, M.D.

Endocrinologist

University of Texas MD Anderson Cancer Center Houston, TX

Maria E. Cabanillas, M.D., Endocrinologist, is Assistant Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at The University of Texas MD Anderson Cancer Center, Houston, Texas. Dr. Cabanillas's clinical focus is metastatic thyroid cancer, and her research interests include targeted therapy for metastatic thyroid cancer, as well as supportive care in cancer. She is a graduate of The University of Puerto Rico Medical School. She completed a Residency in Internal Medicine at the University of Texas Health Science Center at Houston, Houston, Texas, and a Fellowship at Baylor College of Medicine, Houston, Texas. She has authored many peer-reviewed journal articles.

Mark S. Chambers, D.M.D., M.S.

Dentist/Oral Oncologist

University of Texas MD Anderson Cancer Center Houston, TX

Mark S. Chambers, D.M.D., M.S., is a professor in the Department of Head and Neck Surgery at University of Texas MD Anderson Cancer Center, and also serves in the Department of Radiation Oncology at MD Anderson Cancer Center. A graduate of the University of Louisville School of Dentistry, he also has a degree in Biological Sciences from the University of Louisville Medical School, and in Chemical Engineering and Biology from Brescia College. He is Chief of Oncologic Dentistry, Director of the Clinical Research Program, and Director of Rotating Residents in the Surgery Division of the Department of Head and Neck Surgery. His work with the American Academy of Maxillofacial Prosthetics has led to the advancement of the field as well as the development of the Head and Neck Surgery Department at MD Anderson Cancer Center.

Gary L. Clayman, D.M.D., M.D., F.A.C.S.

Thyroid Cancer Surgeon

Clayman Thyroid Cancer Center Tampa, FL

Gary L. Clayman, D.M.D., M.D., F.A.C.S., Thyroid Cancer Surgeon, is founder and director of Clayman Thyroid Cancer Center, Tampa, Florida, an interdisciplinary program in partnership with Tampa General Hospital. Prior to founding Clayman Thyroid Cancer Center, Dr. Clayman spent 27 years as a head and neck endocrine surgeon at the University of Texas MD Anderson Cancer Center. There, he served as the Distinguished Chair of Head and Neck Surgery and Chief of Head and Neck Endocrine Surgery for 13 years.

Ezra E.W. Cohen, M.D.

Oncologist

Moores Cancer Center in San Diego San Diego, CA

Ezra E.W. Cohen, M.D., Oncologist and internationally known translational researcher, is team leader in Head and Neck Oncology and the Solid Tumor Therapeutics research program at Moores Cancer Center, where he is also Associate Director for Translational Science and chair of the Cancer Immunotherapy Program. His research focuses on developing novel agents in head and neck and thyroid cancers as well as on immuno-oncology. He is Editor-in-Chief of Oral Oncology. He chairs the National Cancer Institute’s Head and Neck Cancer Steering Committee that oversees NCI-funded clinical research in head and neck cancer. Previously he co-directed the Head and Neck Cancer Program at the University of Chicago Comprehensive Cancer Center. He chaired the two most recent international Multidisciplinary Head and Neck Cancer Symposia, has authored numerous papers, and has presented his research at national and international meetings. Dr. Cohen completed residencies in Family Medicine at the University of Toronto, in Internal Medicine at Albert Einstein College of Medicine, and completed a Hematology/Oncology fellowship at the University of Chicago, where he was named chief fellow.

Jeffrey A. Cooper, M.D.

Nuclear Medicine Physician

WIRB-Copernicus Group Princeton, NJ

Jeffrey A. Cooper, M.D. is Vice President for Process and Strategic Improvement at WIRB-Copernicus Group. He is a physician who trained in pediatrics, pediatric pulmonary disease, and nuclear medicine. During his academic career he was a basic science investigator, clinical investigator, IRB chair, and hospital administrator. Dr. Cooper left medical practice in 2002 to help start the Association for Accreditation of Human Research Protection Programs, Inc. (AAHRPP) where he was responsible for the development and operation of the accreditation process. Prior to that he was Associate Medical Director at Albany Medical Center where he was responsible for utilization management and quality improvement. Dr. Cooper’s main interest at WIRB Copernicus Group IRB is combining his management and regulatory experience to create systems that promote clinical research while meeting regulatory requirements and high ethical standards. Dr. Cooper received his undergraduate training at Rensselaer Polytechnic Institute and obtained his medical degree from Albany Medical College, and a Masters in Medical Management from H. John Heinz III School of Public Policy and Management at Carnegie Mellon University. He trained in pediatrics at the University of Iowa and trained in nuclear medicine at Albany Medical Center. He is board certified in pediatrics, nuclear medicine and nuclear cardiology. After completion of his post-graduate training, Dr. Cooper trained in pulmonary physiology under a National Research Service Award and has been active in basic science and clinical research.

Gilbert J. Cote, Ph.D.

Molecular Geneticist

University of Texas MD Anderson Cancer Center Houston, TX

Gilbert J. Cote, Ph.D., Researcher, is Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at The University of Texas MD Anderson Cancer Center, Houston, Texas. In 2010 he was named F1000 Faculty Member of the Year. He is co-author of numerous peer-reviewed journal articles on molecular and genetic aspects of medullary thyroid cancer.

Gary L. Francis, M.D., Ph.D.

Endocrinologist

University of Texas Health Science Center San Antonio San Antonio, TX

Gary L. Francis, M.D., Ph.D. received his M.D. and Ph.D. in Biochemistry from the University of Florida and completed his Pediatric Residency at the University of Florida and Yale University. He then specialized with Fellowship Training in Endocrinology, Genetics, and Metabolism at the University of Oklahoma. He joined UT Health in 2018 after holding previous faculty appointments at the National Institutes of Health, The Medical College of Georgia, the Uniformed Services University of the Health Sciences, and Virginia Commonwealth University. He has dedicated the past 25 years to the study of thyroid cancer in children and was chair of the Pediatric Thyroid Cancer Treatment Guidelines Committee of the American Thyroid Association. He currently provides medical care to children with all forms of thyroid cancer and is actively involved in research on thyroid nodules and cancers in children.

Robert F. Gagel, M.D.

Endocrinologist

University of Texas MD Anderson Cancer Center Houston, TX

Robert F. Gagel, M.D., Endocrinologist, is Director, Division of Internal Medicine, and Professor, Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston, as well as Adjunct Professor at Baylor College of Medicine. A graduate of Ohio State University Medical School, he completed postgraduate training at Tufts-New England Medical Center, Harvard Medical School, and Harvard School of Public Health. He is a frequent faculty member at medical meetings, serves on numerous committees and advisory groups for professional organizations, and has authored hundreds of peer-reviewed journal articles and other publications. His studies have focused on transcriptional regulation of the calcitonin gene. He and his colleagues identified the new variant of MEN2. Dr. Gagel has also been active in studies of the development of strategies for treatment of medullary thyroid carcinoma.

Andrew G. Gianoukakis, M.D.

Endocrinologist

University of California - Los Angeles School of Medicine Los Angeles, CA

Dr. Gianoukakis is a Professor of Medicine of the David Geffen School of Medicine at UCLA and an expert in Thyroid Disorders with particular expertise in Advanced Thyroid Cancer and Clinical Trials for Advanced Thyroid Cancer. He directs the Thyroid Clinic and Thyroid Oncology Clinic at Harbor-UCLA where he also serves as Fellowship Training Program Director. Dr. Gianoukakis is a member of the International Thyroid Oncology Group (ITOG) and the Southern California Thyroid Cancer Consortium (SCThyCC).

David Goldenberg, M.D.

Head and Neck Surgeon

Penn State Hershey Medical Center Hershey, PA

David Goldenberg, M.D., F.A.C.S. is a Head and Neck Surgical Oncologist. He was educated at the Ben Gurion University in Israel. He completed a residency in Otolaryngology-Head and Neck Surgery at Rambam Medical Center in Haifa, Israel and then went on to do a three year fellowship in Head and Neck Surgery and Oncology at the Johns Hopkins Hospital in Baltimore. Currently Professor and Chair of the department of Otolaryngology-Head and Neck Surgery at the Penn State Health, Penn State College of Medicine as well as Vice President of Otolaryngology-Head and Neck Surgery at Penn State Health. He combines a busy surgical practice with teaching and research. His clinical practice includes head and neck cancers, thyroid cancers and parathyroid disease, and radiofrequency ablation of thyroid nodules. His clinical research focus is on outcomes and etiology of the rise in incidence of thyroid cancer and his basic research lab and basic research focuses on thyroid cancer genomics in familial non medullary thyroid cancer as well as radiation induced thyroid cancer. Dr Goldenberg is an accomplished and prolific author of over 250 journal articles, 38 book chapters and 7 books in the field of head and neck and thyroid oncology and surgery. His latest book "Head & Neck Endocrine Surgery- A Comprehensive Textbook, Surgical, and Video Atlas (Thieme 2021) is the most comprehensive textbook to date on the subject of Thyroid and parathyroid surgery.

Ann W. Gramza, M.D.

Medical Oncologist

MedStar Georgetown University Hospital Washington, DC

Ann W. Gramza, M.D., is a Medical Oncologist at MedStar Georgetown University Hospital. She is formerly a Staff Clinician at the National Cancer Institute’s Center for Cancer Research at the National Institutes of Health (NIH) in Bethesda, Maryland. She focuses on translational clinical research studies of new treatments for patients with thyroid cancer. Dr. Gramza received her M.D. from The Ohio State University and completed clinical training in internal medicine and palliative care at the University of New Mexico, followed by fellowships in hematology and oncology at Oregon Health and Sciences University (OHSU). She held faculty positions at OHSU and Portland Veterans Affairs Medical Center prior to joining the NIH staff.

Elizabeth G. Grubbs, M.D.

Surgeon

University of Texas MD Anderson Cancer Center Houston, TX

Elizabeth G. Grubbs, M.D., is a Surgeon at the University of Texas MD Anderson Cancer Center, in Houston, Texas. She is also Associate Professor, Department of Surgical Oncology. She earned her M.D. at Duke University School of Medicine in North Carolina, followed by postgraduate training at Duke and at the University of Texas MD Anderson Cancer Center. She is author of numerous peer-reviewed original research articles.

Janis I. Halzel, Pharm.D.

Pharmacist

Halzel and Associates Denver, CO

Janis I. Halzel, Pharm.D., Biogen Idec, works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa’s web site. She also moderates ThyCa's free webinar series, and represents ThyCa at medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center.

Bryan R. Haugen M.D.

Endocrinologist

University of Colorado Health Sciences Center Denver, CO

Bryan R. Haugen, M.D., Endocrinologist, University of Colorado School of Medicine, is Professor of Medicine and Pathology, as well as Head, Division of Endocrinology, Metabolism & Diabetes, and Chair of Endocrine Neoplasms Research. Dr. Haugen’s clinical and research interests focus on thyroid cancer, including molecular therapeutic targets. Specific areas of research include nuclear hormone receptors (RXR, TR, PPAR) and kinase signaling pathways as therapeutic targets in thyroid cancer, as well as proteomic approaches to molecular markers in thyroid neoplasms. He presented a ThyCa Webinar on Thyrogen in September 2012, available on ThyCa's web site. Dr. Haugen is a past President of the American Thyroid Association.

Mimi I. Hu, M.D.

Endocrinologist

University of Texas MD Anderson Cancer Center Houston, TX

Mimi I. Hu, MD, is an endocrinologist and professor at the University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Hu has served on the faculty at MD Anderson Cancer Center since 2007. Her clinical expertise is in the evaluation and treatment of patients with papillary, follicular, and medullary thyroid cancers, hereditary endocrine neoplasia disorders, and metabolic bone and mineral disorders. She is the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid cancer. Dr. Hu has published articles and book chapters evaluating the management of medullary thyroid cancer, multiple endocrine neoplasia, bone health in cancer patients, endocrine complications of head and neck surgery, and paraneoplastic endocrine disorders.

Paul W. Ladenson, M.D.

Endocrinologist

Johns Hopkins Medical Institutions Baltimore, MD

Paul W. Ladenson, M.D. is Director of Endocrinology and Metabolism and The Johns Hopkins Thyroid Tumor Center, as well as Medical Director of The Johns Hopkins Diabetes and Endocrinology Network. He is also Professor of Oncology at The Johns Hopkins University School of Medicine. He graduated from Harvard Medical School and was a resident in medicine, fellow in primary care medicine, and clinical and research fellow in the endocrine and thyroid units of Massachusetts General Hospital. His major research interests include thyroid carcinoma and cost-effectiveness of diagnostic and therapeutic strategies for thyroid diseases. He is on the editorial board of Thyroid and is Associate Editor-Elect (for Thyroidology) of the Journal of Clinical Endocrinology and Metabolism. In 2000 he received the Robert Graves Award from The Thyroid Society.

Stephanie L. Lee, M.D., Ph.D.

Endocrinologist

Boston Medical Center Boston, MA

Stephanie L. Lee, M.D., Ph.D., F.A.C.E., Endocrinologist, is Associate Professor of Medicine at Boston University School of Medicine as well as Director of the Thyroid Disease Center at Boston Medical Center. She is a graduate of the University of California, San Diego, School of Medicine and earned her Ph.D. in Physiology and Pharmacology at the University of California, San Diego. Her postgraduate training included residency at the University of California, San Diego Medical Center and Clinical Fellowship in Endocrinology and a Research Fellowship in Molecular Medicine at the New England Medical Center. Her clinical and research interests are the Etiology and Treatment of Thyroid Disease. She recently participated in writing the American Thyroid Association Evidence-based Guidelines for the diagnosis and management of thyroid nodules and cancer and was named in Boston Magazine’s “Boston’s Top Doctors” and the “Guide to America’s Top Physicians.”

Jochen H. Lorch, MD, MSc

Medical Oncologist

Northwestern Medical Group Chicago, IL

Jochen H. Lorch, MD, MSc graduated from the University of Regensburg in Germany in 1993 and completed his internship and residency at the University of Pennsylvania/Presbyterian Medical Center in 1999. He was awarded a fellowship in hematology and oncology at Northwestern University in Chicago. In 2002, he returned to Germany to complete his German Board Certification in Internal Medicine and Medical Oncology. He returned to the US in 2005 to take a faculty position at Boston University in Boston, MA and started as a faculty member at Dana Farber Cancer Institute in Boston, MA in 2008. He became the inaugural director of the Thyroid Center at Dana Farber. In 2021 he left Dana Farber as Associate Professor of Medicine to join the faculty at Northwestern University where he is Professor of Medicine and Medical Director of the Head and Neck and Thyroid Programs. He lives with his wife and 2 children in Evanston and enjoys science, woodworking and lake Michigan.

Mira M. Milas, M.D.

Endocrine Surgeon

Banner - University Medical Center Phoenix Phoenix, AZ

Mira M. Milas, M.D., F.A.C.S., Endocrine Surgeon, is Professor of Surgery and Chief of Endocrine Surgery at the Banner - University Medical Center in Phoenix, Arizona. Previously, she was an Endocrine Surgeon at the Oregon Health & Science University Knight Cancer Institute in Portland, Oregon. Prior to that she was an Associate Professor at the Cleveland Clinic Lerner College of Medicine. After graduating from Rice University and the University of Texas Medical School at Houston, she completed specialty training at Emory University, Atlanta, Georgia; Emory University Hospitals and School of Medicine and the University of Texas M.D. Anderson Cancer Center in Houston. She has received numerous awards and honors, including being named in the Guide to America’s Top Surgeons 2007 by the Consumers’ Research Council of America. She is extensively involved in research as well as in training other medical professionals. At ThyCa events, her sessions have included thyroid cancer basics for newcomers, thyroid surgery in complex situations including liver metastases, and physician-patient communications.

David Myssiorek, M.D.

Otolaryngologist

Bronxcare Health System Bronx, NY

David Myssiorek, M.D., F.A.C.S. is an ENT-Otolaryngologist at Bronxcare Health System, Bronx, NY. A graduate of New York University School of Medicine, Dr. Myssiorek did his internship at Lenox Hill Hospital and was Chief Resident at New York University/Bellevue. He is the author of numerous articles on thyroid cancer surgery and other head and neck surgery. He has conducted numerous surveys of our population to learn more from us, with his survey on patients’ voice issues receiving more than 6,000 responses. At ThyCa conferences Dr. Myssiorek has spoken about general surgical issues and issues related to having additional neck surgeries, as well as on the causes, prevention, and solutions for voice issues.

Barry D. Nelkin, Ph.D.

Researcher

Johns Hopkins University School of Medicine Baltimore, MD

Barry D. Nelkin Ph.D., is a Laboratory Scientist and Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital in Baltimore, Maryland. His interests include Molecular Mechanisms of Thyroid and Lung Cancers. He received his Ph.D., at George Washington University in Washington, D.C. and completed his postdoctoral fellowship at Johns Hopkins Kimmel Cancer Center.

Yuri E. Nikiforov, M.D., Ph.D.

Pathologist

University of Pittsburgh Medical Center Pittsburgh, PA

Yuri E. Nikiforov, M.D., Ph.D. is Vice-Chair for Molecular Pathology and Director, Division of Molecular and Genomic Pathology at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania. Dr. Nikiforov oversees the operations of the Molecular and Genomic Pathology laboratory in the Clinical Lab Building; he oversees and participates in clinical sign out in the Division. He also serves at Co-Director, Multidisciplinary Thyroid Center at UPMC. His clinical expertise is in surgical pathology of the thyroid gland and in molecular testing of thyroid other tumors. His research is focused on thyroid cancer genetics and mechanisms of chromosomal rearrangements and other mutations induced by ionizing radiation in thyroid cells and other cell types. He has received the Van Meter Award from the American Thyroid Association, as well as The Endocrine Society;s International Award for Publishing Excellence in The Journal of Clinical Endocrinology & Metabolism.

Sareh Parangi, M.D.

Surgeon

Massachusetts General Hospital Boston, MA

Sareh Parangi, M.D. is a busy endocrine surgeon at Massachusetts General Hospital, Harvard Medical School. She is dedicated to personalized care of patients with thyroid cancer. She focuses her clinical efforts on endocrine surgery and applies her basic science knowledge and expertise to tumor progression in thyroid cancer. She also has expertise in molecular biology and has published numerous articles. She has been a council member for The American Association of Endocrine Surgeons. She was a recipient of one of ThyCa’s Thyroid Cancer Research Grants. She has won numerous awards for her research on understanding the role of the BRAF oncoprotein, why some patients with thyroid cancer do worse than others, and how to help them. Her work in thyroid cancer details certain key genetic changes seen more frequently in those who do poorly, to help elucidate the role of these genetic changes in the aggressive behavior of those cancers and on clarifying the molecular mechanism of thyroid cancer invasion and understanding the process of disease progression in patients with thyroid cancer.

Gregory W. Randolph, M.D.

Otolaryngologist

Massachusetts Eye and Ear Infirmary Boston, MA

Gregory W. Randolph, M.D., is an Otolaryngologist, at the Massachusetts Eye and Ear Infirmary, where he directs the thyroid clinic. He is also Clinical Associate in the Division of Surgical Oncology at Massachusetts General Hospital, and Associate Professor of Otology and Laryngology at Harvard Medical School. His main clinical interest is thyroid and parathyroid surgery. He earned his medical degree with research honors at Cornell Medical College, New York, and completed postdoctoral training in otolaryngology at the Massachusetts Eye and Ear Infirmary, Boston, Massachusetts. He serves on numerous hospital and national committees, and is the author of numerous articles and book chapters, is editor of medical texts, and has contributed to practice guidelines for thyroid cancer management. He serves on the editorial board of Head and Neck Journal.

Scot C. Remick, M.D.

Medical Oncologist

Maine Medical Center Cancer Institute Scarborough, ME

Scot C. Remick, M.D. is a Medical Oncologist at Maine Medical Center Cancer Institute in Scarborough, Maine. He graduated from New York Medical College and then completed his residency at The Johns Hopkins Hospital and his fellowship at University of Wisconsin. Dr. Remick is American Board Certified in Internal Medicine as well as Medical Oncology. His special interests include AIDS Malignancies, AIDS Research, Developmental Therapeutics, General Oncology, Melanoma, and Thyroid Cancer.

Matthew D. Ringel, M.D.

Endocrinologist

Ohio State University Comprehensive Cancer Center Columbus, OH

Matthew D. Ringel, M.D., Endocrinologist, is a thyroid cancer specialist and professor at The Ohio State University Hospital and Research Institute. His research focuses on the molecular mechanisms involved in thyroid cancer invasion and new drug testing for thyroid cancer treatment. The focus of his group has been on clarifying the role of the PI3 kinase/Akt pathway in cancer invasion and metastasis, and on identification of novel endogenous metastasis inhibitor pathways in thyroid cancer. He earned his M.D. degree at Pennsylvania State University, followed by internship and residency at Georgetown University, and a fellowship at Johns Hopkins University.

Benjamin R. Roman, M.D., M.S.H.P.

Head and Neck Surgeon and Health-Services Researcher

Memorial Sloan-Kettering Cancer Center New York, NY

Benjamin R. Roman, M.D., M.S.H.P. is a board-certified head and neck surgeon and health-services researcher. With his colleagues at Memorial Sloan-Kettering Cancer Center in New York, New York. He practices a team approach and they are focused on achieving excellent results for their patients by helping them choose the best techniques and treatments for their individual circumstances and needs.

Pamela Schultz, Ph.D., R.N., M.S.

Nursing Professor/Researcher

New Mexico State University Las Cruces, NM

Pamela Schultz, R.N., Ph.D. is Professor of Nursing and Interim Director of the School of Nursing at New Mexico State University in Las Cruces, New Mexico. Her interests include Mental Health and Oncology Research Projects regarding Long-Term Cancer Survivorship and the quality of life of cancer survivors. Previously she was Program Director for Endocrinology in the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston, Texas, where she worked for more than 30 years. In addition to her nursing and doctoral degrees, she has a master’s degree in psychiatric mental health nursing and has facilitated cancer support groups for families and patients.

Martin Schlumberger, M.D.

Endocrinologist

Institute Gustave Roussy Paris, France

Martin Schlumberger, MD, is Professor of Oncology at the University Paris-Sud 11, France, and Chairman of the Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Villejuif, France. He is involved in Nuclear Medicine and in the diagnosis, treatment and follow-up of endocrine tumors, with thyroid cancer and in particular refractory patients being his main field of interest

Manisha H. Shah, M.D.

Oncologist and Hematologist

Ohio State College of Medicine Columbus, OH

Manisha H. Shah, M.D., Oncologist, is Professor at the Ohio State University College of Medicine. Her clinical research interests include thyroid cancer, neuroendocrine cancers, and adrenal cancers. Her group focuses on discovering new targeted therapies and conducts phase II-III clinical trials, leading many national studies. The group also conducts pre- clinical studies to learn types of drugs and combination of drugs and apply that knowledge to design clinical trials. Dr. Shah is the author of numerous articles.

Eric J. Sherman, M.D.

Oncologist

Memorial Sloan-Kettering Cancer Center New York, NY

Eric J. Sherman, M.D., Oncologist, Memorial Sloan-Kettering Cancer Center, New York City, New York, received his medical training at Columbia University College of Physicians and Surgeons, and did his residencies at New York University/Bellevue Medical Center. After a fellowship at the Memorial Sloan Kettering Cancer Center, he joined the Head and Neck Oncology Service there, where he specializes in thyroid cancer and head and neck cancers. Much of his research focuses on targeted therapy in the treatment of thyroid cancers (differentiated thyroid cancer, medullary thyroid cancer, and anaplastic thyroid cancer). Dr. Sherman is board certified in internal medicine and medical oncology.

Steven I. Sherman, M.D.

Endocrinologist

University of Texas MD Anderson Cancer Center Houston, TX

Steven I. Sherman, M.D., Endocrinologist, is Chair of the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center, Houston, Texas, where he is also a Professor. He is also Adjunct Associate Professor of Medicine at Baylor College of Medicine. A Magna Cum Laude graduate of Harvard College, he received his M.D. from Johns Hopkins School of Medicine, followed by internship, residency, and fellowship at Johns Hopkins Hospital, Baltimore, Maryland, and 3 years as a Clinical Associate Physician, National Institutes of Health, Bethesda, Maryland. His research interests include novel therapies for thyroid carcinoma and recombinant human TSH. He is coauthor of the American Thyroid Association Guidelines on Differentiated Thyroid Cancer and a Board Member of the American Thyroid Association.

Peter A. Singer, M.D.

Endocrinologist

University of Southern California Keck School of Medicine Los Angeles, CA

Peter A. Singer, M.D., Endocrinologist, graduated from the Medical School of the University of California at San Francisco, and did his internship at Los Angeles County General Hospital (now LAC-USC Medical Center). He then served two years in the military, including a tour of duty in Vietnam. Dr. Singer then returned to LAC-USC for a medical residency and an NIH-funded endocrine fellowship. He was for many years a faculty member of the USC Division of Endocrinology at USC. In 1991, Dr. Singer moved his practice to USC and, since then has been Professor and Chief of Clinical Endocrinology at the Keck School of Medicine, USC. In addition to a full-time clinical practice in endocrinology, he also teaches medical students, residents and endocrine fellows. In 2004, Dr. Singer was named the Outstanding Clinical Endocrinologist by the American Association of Clinical Endocrinologists. He is a Past President, of the American Thyroid Association.

Jennifer A. Sipos, M.D.

Endocrinologist

The Ohio State University College of Medicine Columbus, Ohio

Jennifer A. Sipos, M.D., is Associate Professor in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University College of Medicine, Columbus, Ohio. Her clinical and research interests are thyroid cancer, general thyroid disorders, and thyroid physiology. Dr. Sipos has authored numerous journal articles and serves as a member of the National Cancer Institute’s Physician Data Query Cancer Genetics Editorial Board. Following her graduation from medical school, Dr. Sipos completed a residency at Wake Forest University Baptist Medical Center and a fellowship at the University of North Carolina Hospitals.

Monica C. Skarulis, M.D.

Endocrinologist

National Institutes of Health Bethesda, MD

Monica C. Skarulis, M.D. is an Endocrinologist in the National Institutes of Diabetes, Digestive & Kidney Diseases (NIDDK) at the National Institutes of Health in Bethesda, Maryland. . She is Section Chief, Clinical Endocrinology Section, Diabetes, Endocrinology and Obesity Branch. Dr. Skarulis has received three commendations from the U.S. Public Health Service. She has been honored with the NIH Director’s Award of Merit and has been recognized for her teaching by NIH fellows and the Uniformed Services University of the Health Sciences. Dr. Skarulis earned her medical degree from New York Medical College. She completed an internship and residency in internal medicine at Cornell University Medical College and an endocrine fellowship at NIH.

Robert C. Smallridge, M.D.

Endocrinologist

Mayo Clinic Jacksonville, FL

Robert C. Smallridge, M.D. has been a member of the Mayo Clinic staff in Jacksonville, Florida since February 1996. He has served as the Chair of the Division of Endocrinology, the Medical Director of the Clinical Studies Unit, the Director of Research, and as a member of the Board of Governors. His clinical practice is focused on thyroid disorders, and particularly thyroid cancer where he collaborates with colleagues in the Department of Cancer Biology on basic and translational studies and with the Division of Oncology on clinical trials. He received the Department of Medical Outstanding Research Award in 2010 and the Distinguished Mayo Clinician Award in 2013. He is a past president of the American Thyroid Association. Prior to joining Mayo Clinic, Dr. Smallridge retired as a Colonel after 23 years in the US Army Medical Corps. He served as the Director of the Department of Medicine at the Walter Reed Army Institute of Research, as Chair of the Endocrinology Division at the Uniformed Services University of the Health Sciences, and as the Endocrinology Consultant to members of the United States Congress.

Julie Ann Sosa, M.D., M.A.

Endocrine and Oncologic Surgeon

University of California, San Francisco San Francisco, CA

Julie Ann Sosa, M.D., M.A., is an Endocrine and Oncologic Surgeon at the University of California, San Francisco. Her previous position was at Duke University Medical Center in Durham, North Carolina. She is principal investigator or co-principal investigator of studies of new drug treatments for differentiated thyroid cancer (papillary/follicular), medullary thyroid cancer, and anaplastic thyroid cancer. Following undergraduate education at Princeton University, she received a master's degree in Human Sciences at the University of Oxford in the United Kingdom and her medical degree from Johns Hopkins University School of Medicine, Baltimore, Maryland. She received postgraduate training at Johns Hopkins Hospital in Baltimore, Maryland, as well as John Radcliffe and Churchill Hospitals, Oxford, England. She is a frequent invited lecturer and course leader/instructor for professional audiences.

Carole A. Spencer, Ph.D., F.A.C.B.

Thyroglobulin Researcher

University of Southern California Endocrine Services Laboratory Los Angeles, CA

Carole A. Spencer, Ph.D., F.A.C.B., is Professor of Medicine in the Keck School of Medicine at USC, where she also is a licensed medical technologist, and directs the USC Endocrine Laboratories. Dr. Spencer received a B.S. in Applied Biochemistry from Bath University of Technology in England, U.K., and a Ph.D. from the Department of Medicine at Glasgow University, Scotland, U.K. In 1977, she joined the University of Southern California in Los Angeles. The author or co-author of more than 80 original papers, chapters and monographs, Dr. Spencer has focused her research on the clinical and laboratory aspects of thyroid disease and treatment. She is a Past President of the American Thyroid Association.

David L. Steward, M.D. F.A.C.S.

Otolaryngologist

University of Cincinnati Academic Health Center Cincinnati, OH

David L. Steward, M.D. F.A.C.S. is a Professor of Otolaryngology-Head and Neck Surgery at the University of Cincinnati Academic Health Center, Cincinnati, Ohio. He is the Director of Head and Neck Surgery Division and Director of Parathyroid /Thyroid Surgery Program. He joined University of Cincinnati Physicians in July 1999. Dr. Steward received his undergraduate degree from Stanford University in 1989 and his Medical Degree, General Surgery, and Otolaryngology residency training at the University of Cincinnati Academic Health Center (1994, 1995, and 1999 respectively). He also serves as Director of Clinical and Resident Research for the Department of Otolaryngology-Head and Neck Surgery at the University of Cincinnati Academic Health Center. His primary interest is in Thyroid and Parathyroid Disease. He holds a secondary appointment as Professor of the Division of Endocrinology, Department of Internal Medicine.

Ralph P. Tufano, M.D., M.B.A., F.A.C.S.

Endocrine Surgeon

Sarasota Memorial Health Care System Sarasota, FL

Ralph Tufano, M.D., M.B.A., F.A.C.S., is the Charles W. Cummings MD Endowed Professor in the Department of Otolaryngology-Head and Neck Surgery at the Johns Hopkins University School of Medicine from 2012-2021. Dr. Tufano has served as the department’s Director of the Division of Head and Neck Endocrine Surgery since 2011 and the American Head and Neck Society accredited fellowship in Endocrine Surgery. He has served on the Board of the American Thyroid Association (ATA). He was also instrumental in the establishment of the Surgical Affairs Committee for the ATA and served as its inaugural co-chair. He is also the recent past chair of the American Academy of Otolaryngology’s Endocrine Surgery Committee and serves on the American Head and Neck Society’s Endocrine Section Board. He has authored over 200 peer-reviewed papers, and more than 40 textbook chapters related to thyroid and parathyroid diseases. His research interests include novel directed therapies for the treatment of thyroid and parathyroid diseases, clinical outcomes research including transoral thyroid and parathyroid surgery, and determining the value propositions for thyroid and parathyroid surgical care episodes. After 21 years at the Johns Hopkins Medical Institutions, Dr. Tufano joined the Sarasota Memorial Health Care System in 2021 to direct the First Physicians Group Multidisciplinary Head and Neck Endocrine Center that consists of a dedicated Thyroid and Parathyroid Center and Head and Neck Cancer Center.

R. Michael Tuttle, M.D.

Endocrinologist

Memorial Sloan-Kettering Cancer Center New York, NY

R. Michael Tuttle, M.D. is an Endocrinologist at Memorial Sloan-Kettering Cancer Center, New York, New York. He also serves as Professor of Medicine at the Joan and Sanford I. Weill Medical College of Cornell University in New York, NY. He is an active clinician and researcher specializing in the management of advanced thyroid cancer. He travels extensively both within the US and abroad lecturing on the difficult management issues in thyroid cancer. His research projects in radiation- induced thyroid cancer have taken him from Kwajalein Atoll in the Marshall Islands to the Hanford Nuclear power-plant in Washington State to regions in Russia that were exposed to fallout from the Chernobyl accident. He serves on the American Thyroid Association committee that produced the current guidelines for the management of benign and malignant thyroid nodules. He also chaired the National Comprehensive Cancer Network Thyroid Cancer Panel, and served on the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug, and as a consultant.

Douglas Van Nostrand, M.D.

Nuclear Medicine Physician

Washington Hospital Center Washington, DC

Douglas Van Nostrand, M.D., Nuclear Medicine Physician, is Director of Nuclear Medicine of the Division of Medicine at Washington Hospital Center in Washington, DC. He is also Professor of Medicine at Georgetown University Hospital and Director of the Washington Hospital Center’s nuclear medicine residency program. Prior to joining the Hospital Center, Dr. Van Nostrand was director of nuclear medicine at Good Samaritan Hospital in Baltimore, Maryland, after serving in the United States Army as director of nuclear medicine at Walter Reed Army Medical Center and in the US Air Force as director of nuclear medicine at Malcolm Grow Medical Center in Washington, D.C. Dr. Van Nostrand completed his postgraduate training in internal medicine at Wilford Hall Medical Center in San Antonio, Texas, and his nuclear medicine training at the National Naval Medical Center in Bethesda, Maryland. He has an M.D. degree from Emory University School of Medicine and a B.S. from Duke University. He has held numerous leadership positions, has received numerous awards, and has authored or coauthored more than 100 abstracts, articles, and chapters. He also has edited and co-edited seven medical books for professionals and patients including the patients’ reference Thyroid Cancer: A Guide for Patients, and the medical textbook co-authored with Dr. Leonard Wartofsky, Thyroid Cancer: A Comprehensive Guide to Clinical Management.

Steven G. Waguespack, M.D.

Endocrinologist

University of Texas MD Anderson Cancer Center Houston, TX

Steven G. Waguespack, M.D., Endocrinologist, is an associate professor of internal medicine and pediatrics at the University of Texas MD Anderson Cancer Center in Houston. A native of Louisiana, Dr. Waguespack graduated Summa Cum Laude from Loyola University in New Orleans, where he also participated in the presidential scholars honor program. He graduated from the University of Texas-Houston Medical School with honors and pursued training in internal medicine/pediatrics at Indiana University Medical Center in Indianapolis. He completed a combined adult and pediatric endocrinology fellowship at Indiana University and is board certified in both subspecialties. Recognized as one of “America’s Top Doctors for Cancer” in pediatric endocrinology, his major clinical and research interests are thyroid cancer, pituitary tumors, and metabolic bone disease. At MD Anderson Cancer Center, Dr. Waguespack provides endocrine care to patients of all ages.

Leonard Wartofsky, M.D.

Endocrinologist

Washington Hospital Center Washington, DC

Leonard Wartofsky, M.D. is an endocrinologist at the Washington Hospital Center in Washington D.C. He is also editor of the medical textbook Thyroid Cancer: A Comprehensive Guide to Clinical Management and is co-editor of a thyroid cancer patient education book in progress. In addition to his position at the Washington Hospital Center, Dr. Wartofsky is a professor of medicine, anatomy, physiology and genetics at the Uniformed Services University of the Health Sciences in Bethesda, MD, professor of medicine at Georgetown University and clinical professor of medicine at the University of Maryland, Howard University and George Washington University Schools of Medicine. He is a past president of both The Endocrine Society and the American Thyroid Association and a recipient of the Distinguished Educator Award of The Endocrine Society. An internationally renowned expert in clinical thyroid disease with emphasis on patients with thyroid cancer, Dr. Wartofsky has published more than 300 articles and book chapters and has lectured across the globe.

Samuel A. Wells, M.D.

Surgeon

National Cancer Institute NIH, Bethesda, MD

Samuel A. Wells, M.D., Surgeon, is Senior Clinician and Director of the Thyroid Clinical Research Program in the Medical Oncology Branch at the Center for Cancer Research at the National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland. His career has focused on research and treatment for medullary thyroid cancer, including Multiple Endocrine Neoplasia syndromes. His primary focus is the study of molecular targeted therapeutics. Dr. Wells received his M.D. from Emory University, followed by a residency at Duke University. From 1981 to 1998 he was Chair of the Department of Surgery at Washington University School of Medicine. He was a Clinical Associate, and later a Senior Investigator, in the Surgery Branch of the NCI. He was also a Guest Investigator at the Karolinska Institute in Stockholm, Sweden.

Lori J. Wirth, M.D.

Medical Oncologist

Massachusetts General Hospital Cancer Center Boston, Massachusetts

Lori J. Wirth, M.D., Medical Oncologist, is Assistant Professor in Medicine at Harvard Medical School and at Massachusetts General Hospital, and clinician in the Head and Neck Oncology Program at the Massachusetts General Hospital Cancer Center, all in Boston, Massachusetts, where thyroid tumors are one of her specialties. Dr. Wirth graduated from Brown University and received her M.D. from Columbia University College of Physicians and Surgeons in New York. She completed a residency in Internal Medicine at New York Presbyterian Hospital and then became a fellow in Medical Oncology at the Dana-Farber Cancer Institute. She is a member of the National Cancer Institute’s Metastatic/Recurrent Disease Task Force/Head and Neck Steering Committee, as well as a Thyroid Cancer Guideline Panel Member of the National Comprehensive Cancer Network. Dr. Wirth has given numerous invited presentations at the regional, national, and international levels and has authored numerous publications. She is also a reviewer for medical journals.

Mark E. Zafereo, M.D.

Head and Neck Surgeon

University of Texas MD Anderson Cancer Center Houston, TX

Mark E. Zafereo, M.D. is an Associate Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas. He is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Endocrine Center at MD Anderson Cancer Center. Dr. Zafereo holds national committee appointments for the American Head and Neck Society, American Academy of Otolaryngology-Head and Neck Surgery, and American Board of Otolaryngology-Head and Neck Surgery, and he is a Past President of the Houston Society of Otolaryngology-Head and Neck Surgery. He has published extensively on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients with thyroid cancer and parathyroid neoplasms.

Donald Margouleff, M.D.

Nuclear Medicine Physician

In Memory and Gratitude

Donald Margouleff, M.D., was a Nuclear Medicine Physician at North Shore University Hospital, Manhasset, New York. He was also Clinical Professor at New York University Langone Medical Center. He was a member of the editorial board of the journal Clinical Nuclear Medicine.

Ernest L. Mazzaferri, M.D.

Endocrinologist

In Memory and Gratitude

Ernest L. Mazzaferri, M.D., M.A.C.P. was an Endocrinologist and past president of the American Thyroid Association (ATA), as well as a member of ATA’s Guidelines Task Force that developed ATA’s official clinical guidelines (2006) for managing thyroid nodules and differentiated thyroid cancer. Dr. Mazzaferri was a Master of the American College of Physicians, an award given to approximately 300 people in the US. He was also a member of the Board of Directors of the American Board of Internal Medicine (ABIM) and served as Chair of the ABIM Subspecialty Board in Endocrinology. Dr. Mazzaferri had a long and distinguished career in thyroid cancer treatment and research at Ohio State University and in recent years at the University of Florida. He was a graduate of Ohio State University College of Medicine, chaired the National Cancer Center Network panel that issued guidelines for managing thyroid cancer, and was author and editor of over 200 peer-reviewed publications as well as textbooks on endocrinology and thyroid cancer. He was editor of Clinical Thyroidology and received many awards. He wrote the foreword for the patient reference book, Thyroid Cancer: A Guide for Patients.

Bryan McIver, M.D., Ch.B., Ph.D.

Endocrinologist

In Memory and Gratitude

Bryan McIver, M.B., Ph.D., F.R.C.P., was an Endocrinologist. He had extensive experience treating patients with thyroid diseases, specifically those faced with aggressive thyroid cancers. He ran a research lab, worked on thyroid cancer genetics and new treatments for patients with thyroid cancer. He received numerous awards and honors. He graduated Summa Cum Laude in Medical Sciences from the University of Edinburgh in Scotland, received his Ph.D. in Physiology and Biophysics from the University of Vermont; and his M.B. Ch.B. Faculty of Medicine at the University of Edinburgh.

Jeffrey F. Moley, M.D.

Surgeon

In Memory and Gratitude

Jeffrey F. Moley, M.D., Surgeon, was Professor of Surgery, Chief of Endocrine and Oncologic Surgery, and Associate Director of the Siteman Cancer Center at the Washington University School of Medicine. He was also Chief of the Surgical Service, at the St. Louis VA Medical Center. Since 2005 he also served on the American Board of Surgery Surgical Oncology Advisory Committee. Dr. Moley was study chair and principal investigator of clinical trials and studies of treatments for metastatic medullary thyroid cancer and differentiated thyroid cancer. A graduate of Harvard University and Columbia University Medical School, he completed post-graduate training at Yale-New Haven Hospital and the National Cancer Institute. The author of dozens of articles as well as books and monographs, Dr. Moley also served on the editorial boards of the American Journal of Clinical Oncology and the Journal of Surgical Oncology.

Yolanda C. Oertel, M.D.

Cytopathologist

In Memory and Gratitude

Yolanda C. Oertel, M.D. was a Pathologist at the Washington Hospital Center in Washington D.C. She had many years of experience with fine needle aspiration and evaluation of thyroid nodules and trained many other pathologists in these techniques.

Arturo R. Rolla, M.D.

Endocrinologist

In Memory and Gratitude

Arturo R. Rolla, M.D. was an Endocrinologist at Beth Israel Deaconess Medical Center in Boston Massachusetts. He was Assistant Clinical Professor of Medicine at Harvard Medical School and Tufts University School of Medicine in Boston, Massachusetts and received awards for excellence in teaching from both institutions. His research focused on thyroid cancer and other endocrine disorders and he was the author of numerous journal articles and book chapters. Born in Argentina, he graduated Summa Cum Laude from college and medical school at Catholic University of Cordoba. He completed his internship at Mercy Medical Center in Pennsylvania and was chief resident at New England Deaconess Hospital in Boston. He was the owner of the ThyCa listserv, and was integrally involved in the founding of ThyCa.